Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Topical
Parenteral
Thickeners and Stabilizers
Emulsifying Agents
Film Formers & Plasticizers
Rheology Modifiers
API Stability Enhancers
Surfactant & Foaming Agents
Controlled & Modified Release
Direct Compression
Co-Processed Excipients
Coating Systems & Additives
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Aminolevulinic Acid Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aminolevulinic Acid Hydrochloride, including repackagers and relabelers. The FDA regulates Aminolevulinic Acid Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aminolevulinic Acid Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aminolevulinic Acid Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aminolevulinic Acid Hydrochloride supplier is an individual or a company that provides Aminolevulinic Acid Hydrochloride active pharmaceutical ingredient (API) or Aminolevulinic Acid Hydrochloride finished formulations upon request. The Aminolevulinic Acid Hydrochloride suppliers may include Aminolevulinic Acid Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Aminolevulinic Acid Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aminolevulinic Acid Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Aminolevulinic Acid Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Aminolevulinic Acid Hydrochloride DMFs exist exist since differing nations have different regulations, such as Aminolevulinic Acid Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aminolevulinic Acid Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Aminolevulinic Acid Hydrochloride USDMF includes data on Aminolevulinic Acid Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aminolevulinic Acid Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aminolevulinic Acid Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Aminolevulinic Acid Hydrochloride Drug Master File in Japan (Aminolevulinic Acid Hydrochloride JDMF) empowers Aminolevulinic Acid Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Aminolevulinic Acid Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Aminolevulinic Acid Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Aminolevulinic Acid Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aminolevulinic Acid Hydrochloride Drug Master File in Korea (Aminolevulinic Acid Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aminolevulinic Acid Hydrochloride. The MFDS reviews the Aminolevulinic Acid Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Aminolevulinic Acid Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aminolevulinic Acid Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aminolevulinic Acid Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aminolevulinic Acid Hydrochloride suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aminolevulinic Acid Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aminolevulinic Acid Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aminolevulinic Acid Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aminolevulinic Acid Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aminolevulinic Acid Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aminolevulinic Acid Hydrochloride suppliers with NDC on PharmaCompass.
Aminolevulinic Acid Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aminolevulinic Acid Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aminolevulinic Acid Hydrochloride GMP manufacturer or Aminolevulinic Acid Hydrochloride GMP API supplier for your needs.
A Aminolevulinic Acid Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Aminolevulinic Acid Hydrochloride's compliance with Aminolevulinic Acid Hydrochloride specifications and serves as a tool for batch-level quality control.
Aminolevulinic Acid Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Aminolevulinic Acid Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aminolevulinic Acid Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Aminolevulinic Acid Hydrochloride EP), Aminolevulinic Acid Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aminolevulinic Acid Hydrochloride USP).
LOOKING FOR A SUPPLIER?
